Alpha Synuclein Market Report

Global and Region Alpha Synuclein Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：156
  • REPORT CODE：GMM889469
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Alpha Synuclein market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Alpha Synucleinmarket, defines the market attractiveness level of Alpha Synuclein market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Alpha Synuclein industry, describes the types of Alpha Synuclein market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alpha Synuclein market and the development prospects and opportunities of Alpha Synuclein industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alpha Synuclein market in Chapter 13.

    By Player:

    • ICB International Inc

    • Genmab A/S

    • MedImmune LLC

    • AFFiRiS AG

    • Prothena Corp Plc

    • BioArctic AB

    • reMYND NV

    • QR Pharma Inc

    • AC Immune SA

    • nLife Therapeutics SL

    • H Lundbeck A/S

    • Biogen Inc

    • Evotec AG

    • Neuropore Therapies Inc

    By Type:

    • AV-1950R

    • AV-1947D

    • BAN-0805

    • BIIB-054

    • DPC-003

    • Others

    By End-User:

    • Multiple System Atrophy

    • Neurodegenerative Disease

    • Lewy Body Dementia

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Alpha Synuclein Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Alpha Synuclein Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Alpha Synuclein Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Alpha Synuclein Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Alpha Synuclein Market Analysis and Outlook to 2022

    • 7.1 Global Alpha Synuclein Consumption (2017-2022)

    • 7.2 United States Alpha Synuclein Consumption (2017-2022)

    • 7.3 Europe Alpha Synuclein Consumption (2017-2022)

    • 7.4 China Alpha Synuclein Consumption (2017-2022)

    • 7.5 Japan Alpha Synuclein Consumption (2017-2022)

    • 7.6 India Alpha Synuclein Consumption (2017-2022)

    • 7.7 South Korea Alpha Synuclein Consumption (2017-2022)

    8 Region and Country-wise Alpha Synuclein Market Analysis and Outlook to 2028

    • 8.1 Global Alpha Synuclein Consumption Forecast (2022-2028)

    • 8.2 United States Alpha Synuclein Consumption Forecast (2022-2028)

    • 8.3 Europe Alpha Synuclein Consumption Forecast (2022-2028)

    • 8.4 China Alpha Synuclein Consumption Forecast (2022-2028)

    • 8.5 Japan Alpha Synuclein Consumption Forecast (2022-2028)

    • 8.6 India Alpha Synuclein Consumption Forecast (2022-2028)

    • 8.7 South Korea Alpha Synuclein Consumption Forecast (2022-2028)

    9 Global Alpha Synuclein Market Outlook by Types and Applications to 2022

    • 9.1 Global Alpha Synuclein Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global AV-1950R Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global AV-1947D Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global BAN-0805 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global BIIB-054 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global DPC-003 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Alpha Synuclein Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Multiple System Atrophy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Neurodegenerative Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Lewy Body Dementia Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Alpha Synuclein Market Outlook by Types and Applications to 2028

    • 10.1 Global Alpha Synuclein Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global AV-1950R Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global AV-1947D Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global BAN-0805 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global BIIB-054 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global DPC-003 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Alpha Synuclein Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Multiple System Atrophy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Neurodegenerative Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Lewy Body Dementia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Alpha Synuclein Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Alpha Synuclein Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Alpha Synuclein Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Alpha Synuclein Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Alpha Synuclein Market Competitive Analysis

    • 14.1 ICB International Inc

      • 14.1.1 ICB International Inc Company Details

      • 14.1.2 ICB International Inc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 ICB International Inc Alpha Synuclein Product and Service

    • 14.2 Genmab A/S

      • 14.2.1 Genmab A/S Company Details

      • 14.2.2 Genmab A/S Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Genmab A/S Alpha Synuclein Product and Service

    • 14.3 MedImmune LLC

      • 14.3.1 MedImmune LLC Company Details

      • 14.3.2 MedImmune LLC Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 MedImmune LLC Alpha Synuclein Product and Service

    • 14.4 AFFiRiS AG

      • 14.4.1 AFFiRiS AG Company Details

      • 14.4.2 AFFiRiS AG Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AFFiRiS AG Alpha Synuclein Product and Service

    • 14.5 Prothena Corp Plc

      • 14.5.1 Prothena Corp Plc Company Details

      • 14.5.2 Prothena Corp Plc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Prothena Corp Plc Alpha Synuclein Product and Service

    • 14.6 BioArctic AB

      • 14.6.1 BioArctic AB Company Details

      • 14.6.2 BioArctic AB Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 BioArctic AB Alpha Synuclein Product and Service

    • 14.7 reMYND NV

      • 14.7.1 reMYND NV Company Details

      • 14.7.2 reMYND NV Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 reMYND NV Alpha Synuclein Product and Service

    • 14.8 QR Pharma Inc

      • 14.8.1 QR Pharma Inc Company Details

      • 14.8.2 QR Pharma Inc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 QR Pharma Inc Alpha Synuclein Product and Service

    • 14.9 AC Immune SA

      • 14.9.1 AC Immune SA Company Details

      • 14.9.2 AC Immune SA Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AC Immune SA Alpha Synuclein Product and Service

    • 14.10 nLife Therapeutics SL

      • 14.10.1 nLife Therapeutics SL Company Details

      • 14.10.2 nLife Therapeutics SL Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 nLife Therapeutics SL Alpha Synuclein Product and Service

    • 14.11 H Lundbeck A/S

      • 14.11.1 H Lundbeck A/S Company Details

      • 14.11.2 H Lundbeck A/S Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 H Lundbeck A/S Alpha Synuclein Product and Service

    • 14.12 Biogen Inc

      • 14.12.1 Biogen Inc Company Details

      • 14.12.2 Biogen Inc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Biogen Inc Alpha Synuclein Product and Service

    • 14.13 Evotec AG

      • 14.13.1 Evotec AG Company Details

      • 14.13.2 Evotec AG Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Evotec AG Alpha Synuclein Product and Service

    • 14.14 Neuropore Therapies Inc

      • 14.14.1 Neuropore Therapies Inc Company Details

      • 14.14.2 Neuropore Therapies Inc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Neuropore Therapies Inc Alpha Synuclein Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Alpha Synuclein

    • Figure Alpha Synuclein Picture

    • Table Global Alpha Synuclein Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Alpha Synuclein Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Alpha Synuclein Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Alpha Synuclein Consumption by Country (2017-2022)

    • Figure United States Alpha Synuclein Consumption and Growth Rate (2017-2022)

    • Table Europe Alpha Synuclein Consumption and Growth Rate (2017-2022)

    • Figure China Alpha Synuclein Consumption and Growth Rate (2017-2022)

    • Figure Japan Alpha Synuclein Consumption and Growth Rate (2017-2022)

    • Figure India Alpha Synuclein Consumption and Growth Rate (2017-2022)

    • Figure South Korea Alpha Synuclein Consumption and Growth Rate (2017-2022)

    • Figure Global Alpha Synuclein Consumption Forecast by Country (2022-2028)

    • Figure United States Alpha Synuclein Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Alpha Synuclein Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Alpha Synuclein Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Alpha Synuclein Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Alpha Synuclein Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Alpha Synuclein Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AV-1950R Consumption and Growth Rate (2017-2022)

    • Figure Global AV-1947D Consumption and Growth Rate (2017-2022)

    • Figure Global BAN-0805 Consumption and Growth Rate (2017-2022)

    • Figure Global BIIB-054 Consumption and Growth Rate (2017-2022)

    • Figure Global DPC-003 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Multiple System Atrophy Consumption and Growth Rate (2017-2022)

    • Figure Global Neurodegenerative Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Lewy Body Dementia Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global AV-1950R Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AV-1947D Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BAN-0805 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BIIB-054 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DPC-003 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multiple System Atrophy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurodegenerative Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lewy Body Dementia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Alpha Synuclein Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Alpha Synuclein Export by Region (Top 5 Countries) (2017-2028)

    • Table ICB International Inc (Foundation Year, Company Profile and etc.)

    • Table ICB International Inc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table ICB International Inc Alpha Synuclein Product and Service

    • Table Genmab A/S (Foundation Year, Company Profile and etc.)

    • Table Genmab A/S Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genmab A/S Alpha Synuclein Product and Service

    • Table MedImmune LLC (Foundation Year, Company Profile and etc.)

    • Table MedImmune LLC Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune LLC Alpha Synuclein Product and Service

    • Table AFFiRiS AG (Foundation Year, Company Profile and etc.)

    • Table AFFiRiS AG Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table AFFiRiS AG Alpha Synuclein Product and Service

    • Table Prothena Corp Plc (Foundation Year, Company Profile and etc.)

    • Table Prothena Corp Plc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prothena Corp Plc Alpha Synuclein Product and Service

    • Table BioArctic AB (Foundation Year, Company Profile and etc.)

    • Table BioArctic AB Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioArctic AB Alpha Synuclein Product and Service

    • Table reMYND NV (Foundation Year, Company Profile and etc.)

    • Table reMYND NV Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table reMYND NV Alpha Synuclein Product and Service

    • Table QR Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table QR Pharma Inc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table QR Pharma Inc Alpha Synuclein Product and Service

    • Table AC Immune SA (Foundation Year, Company Profile and etc.)

    • Table AC Immune SA Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table AC Immune SA Alpha Synuclein Product and Service

    • Table nLife Therapeutics SL (Foundation Year, Company Profile and etc.)

    • Table nLife Therapeutics SL Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table nLife Therapeutics SL Alpha Synuclein Product and Service

    • Table H Lundbeck A/S (Foundation Year, Company Profile and etc.)

    • Table H Lundbeck A/S Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table H Lundbeck A/S Alpha Synuclein Product and Service

    • Table Biogen Inc (Foundation Year, Company Profile and etc.)

    • Table Biogen Inc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Inc Alpha Synuclein Product and Service

    • Table Evotec AG (Foundation Year, Company Profile and etc.)

    • Table Evotec AG Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Evotec AG Alpha Synuclein Product and Service

    • Table Neuropore Therapies Inc (Foundation Year, Company Profile and etc.)

    • Table Neuropore Therapies Inc Alpha Synuclein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neuropore Therapies Inc Alpha Synuclein Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US